Exhibit 5.1
| | | | |

| | | | Cira Centre 2929 Arch Street Philadelphia, PA 19104-2808 +1 215 994 4000 Main +1 215 994 2222 Fax www.dechert.com |
November 21, 2023
FS KKR Capital Corp.
201 Rouse Boulevard
Philadelphia, PA 19112
| Re: | Registration Statement on Form N-2 |
Ladies and Gentlemen:
We have acted as counsel to FS KKR Capital Corp., a Maryland corporation (the “Company”), in connection with the preparation and filing of a Registration Statement on Form N-2, filed on October 4, 2021 with the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”) (the “Registration Statement”) and the final prospectus supplement, dated November 13, 2023 (including the base prospectus filed therewith, the “Prospectus Supplement”), filed with the Commission on November 15, 2023 pursuant to Rule 424(b)(2) under the Securities Act, relating to the proposed issuance by the Company of $400,000,000 aggregate principal amount of its 7.875% notes due 2029 (the “Notes”), to be sold to the underwriters pursuant to an underwriting agreement substantially in the form filed as Exhibit 1.1 to the Company’s Current Report on Form 8-K filed with the Commission on November 15, 2023 (the “Underwriting Agreement”). This opinion letter is being furnished to the Company in accordance with the requirements of Item 25 of Form N-2 under the Investment Company Act of 1940, as amended, and we express no opinion herein as to any matter other than as to the legality of the Notes.
The Notes are to be issued pursuant to the indenture dated as of July 14, 2014 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by the first supplemental indenture dated as of July 14, 2014, by the second supplemental indenture dated as of December 3, 2014, by the third supplemental indenture dated as of April 30, 2015, by the fourth supplemental indenture dated as of July 15, 2019, by the fifth supplemental indenture dated as of November 20, 2019, by the sixth supplemental indenture dated as of April 30, 2020, by the seventh supplemental indenture dated as of December 10, 2020, by the eighth supplemental indenture dated as of June 17, 2021, by the ninth supplemental indenture dated as of October 12, 2021, by the tenth supplemental indenture dated as of October 12, 2021, by the eleventh supplemental indenture dated as of January 18, 2022, and by the twelfth supplemental indenture dated as of November 21, 2023 (together with the Base Indenture, the “Indenture”), between the Company and the Trustee.
In rendering the opinions expressed below, we have examined and relied on originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records and other instruments and such agreements, certificates and receipts of public officials, certificates of officers or other representatives of the Company and others, and such other documents as we have deemed necessary or appropriate as a basis for the opinions set forth below, including the following documents: